肿瘤微环境
CTL公司*
免疫系统
癌症研究
结直肠癌
生物
免疫检查点
细胞毒性T细胞
微卫星不稳定性
肿瘤浸润淋巴细胞
CD8型
癌症
免疫疗法
免疫学
遗传学
体外
等位基因
基因
微卫星
作者
Nicolás J. Llosa,Michael Cruise,Ada Tam,Elizabeth C. Wicks,Elizabeth M. Hechenbleikner,Janis M. Taube,Richard L. Blosser,Hongni Fan,Hao Wang,Brandon Luber,Ming Zhang,Nickolas Papadopoulos,Kenneth W. Kinzler,Bert Vogelstein,Cynthia L. Sears,Robert A. Anders,Drew M. Pardoll,Franck Housseau
出处
期刊:Cancer Discovery
[American Association for Cancer Research]
日期:2014-10-31
卷期号:5 (1): 43-51
被引量:1448
标识
DOI:10.1158/2159-8290.cd-14-0863
摘要
UNLABELLED: We examined the immune microenvironment of primary colorectal cancer using immunohistochemistry, laser capture microdissection/qRT-PCR, flow cytometry, and functional analysis of tumor-infiltrating lymphocytes. A subset of colorectal cancer displayed high infiltration with activated CD8(+) cytotoxic T lymphocyte (CTL) as well as activated Th1 cells characterized by IFNγ production and the Th1 transcription factor TBET. Parallel analysis of tumor genotypes revealed that virtually all of the tumors with this active Th1/CTL microenvironment had defects in mismatch repair, as evidenced by microsatellite instability (MSI). Counterbalancing this active Th1/CTL microenvironment, MSI tumors selectively demonstrated highly upregulated expression of multiple immune checkpoints, including five-PD-1, PD-L1, CTLA-4, LAG-3, and IDO-currently being targeted clinically with inhibitors. These findings link tumor genotype with the immune microenvironment, and explain why MSI tumors are not naturally eliminated despite a hostile Th1/CTL microenvironment. They further suggest that blockade of specific checkpoints may be selectively efficacious in the MSI subset of colorectal cancer. SIGNIFICANCE: The findings reported in this article are the first to demonstrate a link between a genetically defined subtype of cancer and its corresponding expression of immune checkpoints in the tumor microenvironment. The mismatch repair-defective subset of colorectal cancer selectively upregulates at least five checkpoint molecules that are targets of inhibitors currently being clinically tested.
科研通智能强力驱动
Strongly Powered by AbleSci AI